Make sure to visit us at booth #K20 for live demos of RetinAI Discovery^® and learn how to unlock the power of data and improve quality of care for patients by leveraging AI.

Join us to discover new features, designed to empower ophthalmologists and optometrists with instant, customizable and actionable insights.

‍

NEW: Introducing RetinAI OCT Atlas^® 

We are proud to announce RetinAI OCT Atlas^®, a CE-marked processor that merges RetinAI Layer Segmentation & Fluid Segmentation processors into a single, comprehensive powerhouse. By expanding the biomarker portfolio and target disease coverage, the RetinAI OCT Atlas^® provides clinicians with unprecedented depth in retinal assessment.

Under this EU-MDR upgrade, Glaucoma joins the RetinAI Discovery^® portfolio of approved indications for RetinAI OCT Atlas, which already includes AMD, nAMD, iAMD, GA, DR, and DME.

The release introduces a significant expansion of RetinAI’s proprietary biomarker portfolio, providing granular segmentation and measurement for:

• Outer Nuclear Layer + Henle’s Fibre Layer (ONL+HFL)
• Myoid Zone (MZ)
•  Ellipsoid Zone (EZ)+Outer Photoreceptor Segment (OPR)+Interdigitation Zone (IZ) (EZ+OPR+IZ)
• Retinal Pigment Epithelium (RPE)
• Amorphous Material (AM), including hyperreflective material in the subretinal space (e.g., fibrosis)

Be among the first to experience the RetinAI OCT Atlas® in person. Join us at 100% Optical for an exclusive 1:1 demo and see how we’re redefining the depth of retinal assessment.

‍🔗 Book your 1:1 demo now!

‍

From Scan to Insight: AI-Powered Retinal Imaging Workflow for Optometry

🗣️ Dr. Trusit Dave 🗓️ Sat 28 Feb, 11:00 🗓️ Sun, 1 March, 13:00

A live, hands-on demonstration of a complete AI-powered retinal imaging workflow. From image acquisition on Heidelberg SPECTRALIS to automated data upload and AI-powered analysis in RetinAI, showing how optometrists can save time and gain deeper insights.

‍

Fully automated End-to-End Imaging Workflow: Heidelberg Engineering SPECTRALIS & Discovery CONNECT^®

See how effortlessly you can sync imaging data to RetinAI Discovery® in <30 seconds per image for smarter workflows, better clinical decisions and maximized efficiency.

Join RetinAI and Heidelberg Engineering for an exclusive, hands-on demo of the most advanced, fully automated imaging workflow in eye care.

Live Demo Schedule at Booth #K20

See LuxIA^® in action!

Come by our stand and learn about our latest AI-powered screening in adult diabetics for more-than-mild diabetic retinopathy (mtmDR) from Color fundus images.

Co-developed by RetinAI andz Fundación Ver Salud, LuxIA® runs as an independent, AI-based device within the CE-marked RetinAI Discovery® platform.

‍